173 related articles for article (PubMed ID: 26637917)
1. Long-term Survivors After Liver Resection for Ovarian Cancer Liver Metastases.
Bacalbaşa N; Balescu I; Dima S; Popescu I
Anticancer Res; 2015 Dec; 35(12):6919-23. PubMed ID: 26637917
[TBL] [Abstract][Full Text] [Related]
2. Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit.
Bacalbasa N; Dima S; Brasoveanu V; David L; Balescu I; Purnichescu-Purtan R; Popescu I
World J Surg Oncol; 2015 Aug; 13():235. PubMed ID: 26243426
[TBL] [Abstract][Full Text] [Related]
3. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic Resection as Part of Cytoreductive Surgery in Advanced-stage and Recurrent Epithelial Ovarian Cancer--A Single-center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Jul; 35(7):4125-9. PubMed ID: 26124365
[TBL] [Abstract][Full Text] [Related]
5. The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer.
Kolev V; Pereira EB; Schwartz M; Sarpel U; Roayaie S; Labow D; Momeni M; Chuang L; Dottino P; Rahaman J; Zakashansky K
Int J Gynecol Cancer; 2014 Jan; 24(1):70-4. PubMed ID: 24356412
[TBL] [Abstract][Full Text] [Related]
6. Splenectomy as Part of Cytoreductive Surgery in Recurrent Epithelial Ovarian Cancer.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Sep; 35(9):5097-101. PubMed ID: 26254413
[TBL] [Abstract][Full Text] [Related]
7. Long-term Survivors After Liver Resection for Breast Cancer Liver Metastases.
BacalbaȘa N; Balescu I; Dima S; Popescu I
Anticancer Res; 2015 Dec; 35(12):6913-7. PubMed ID: 26637916
[TBL] [Abstract][Full Text] [Related]
8. Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver.
Roh HJ; Kim DY; Joo WD; Yoo HJ; Kim JH; Kim YM; Kim YT; Nam JH
Arch Gynecol Obstet; 2011 Nov; 284(5):1223-9. PubMed ID: 21132314
[TBL] [Abstract][Full Text] [Related]
9. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
10. Hepatic resection for metachronous metastases from ovarian carcinoma.
Merideth MA; Cliby WA; Keeney GL; Lesnick TG; Nagorney DM; Podratz KC
Gynecol Oncol; 2003 Apr; 89(1):16-21. PubMed ID: 12694649
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cancer liver metastases--should we apply the principle of optimal cytoreduction to the liver? A review.
Bacalbaşa N; Popescu I
Hepatogastroenterology; 2015; 62(138):355-7. PubMed ID: 25916062
[TBL] [Abstract][Full Text] [Related]
12. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.
Viganò L; Ferrero A; Lo Tesoriere R; Capussotti L
Ann Surg Oncol; 2008 Sep; 15(9):2458-64. PubMed ID: 18463927
[TBL] [Abstract][Full Text] [Related]
13. Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival data.
Manci N; Bellati F; Muzii L; Calcagno M; Alon SA; Pernice M; Angioli R; Panici PB
Ann Surg Oncol; 2006 Dec; 13(12):1717-23. PubMed ID: 16957965
[TBL] [Abstract][Full Text] [Related]
14. Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer.
Gasparri ML; Grandi G; Bolla D; Gloor B; Imboden S; Panici PB; Mueller MD; Papadia A
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1509-20. PubMed ID: 26660323
[TBL] [Abstract][Full Text] [Related]
15. The Role of Re-resection for Breast Cancer Liver Metastases-a Single Center Experience.
BacalbaȘa N; Balescu I; Dima S; Popescu I
Anticancer Res; 2015 Dec; 35(12):6877-80. PubMed ID: 26637910
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of patients with advanced ovarian cancer after resection of liver metastases.
Neumann UP; Fotopoulou C; Schmeding M; Thelen A; Papanikolaou G; Braicu EI; Neuhaus P; Sehouli J
Anticancer Res; 2012 Oct; 32(10):4517-21. PubMed ID: 23060580
[TBL] [Abstract][Full Text] [Related]
17. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
[TBL] [Abstract][Full Text] [Related]
18. Surgery in recurrent epithelial ovarian cancer: benefits on Survival for patients with residual disease of 0.1-1 cm after secondary cytoreduction.
Tian WJ; Jiang R; Cheng X; Tang J; Xing Y; Zang RY
J Surg Oncol; 2010 Mar; 101(3):244-50. PubMed ID: 20112269
[TBL] [Abstract][Full Text] [Related]
19. [Recurrent tumor after R0 resection of colorectal liver metastases. Incidence, resectability and prognosis].
Scheele J; Stangl R; Schmidt K; Altendorf-Hofmann A
Chirurg; 1995 Oct; 66(10):965-73. PubMed ID: 8529448
[TBL] [Abstract][Full Text] [Related]
20. Is There a Role for Tertiary (TCR) and Quaternary (QCR) Cytoreduction in Recurrent Ovarian Cancer?
Fanfani F; Fagotti A; Ercoli A; Gallotta V; Chiantera V; Restaino S; Monterossi G; Scambia G
Anticancer Res; 2015 Dec; 35(12):6951-5. PubMed ID: 26637921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
